Market Closed -
Other stock markets
|
After market 11:04:40 am | |||
0.216 EUR | -1.82% | 0.218 | +0.93% |
22/04 | Mithra Pharmaceuticals Obtains Court Protection Measures | MT |
08/03 | Mithra Pharmaceuticals SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Mithra Pharmaceuticals S.A. explores the potential of the unique native estrogen estetrol in a wide range of applications in women health and beyond. After having successfully launched the first estetrol-based product in 2021, the contraceptive pill Estelle®, the Company is now focusing on its second product Donesta®, the next-generation hormone therapy.
Mithra Pharmaceuticals S.A. also develops and manufactures complex therapeutics in the areas of contraception, menopause and hormone-dependent cancers. It offers partners a complete spectrum of research, development and specialist manufacturing at its technological platform Mithra CDMO.
Number of employees: 270
Sales per Business
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Therapeutic Products
100.0
%
| 23 | 100.0 % | 67 | 100.0 % | +195.56% |
Sales per region
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Europe
76.6
%
| 9 | 41.0 % | 51 | 76.6 % | +452.76% |
International
21.1
%
| 12 | 54.6 % | 14 | 21.1 % | +14.23% |
Belgium
2.3
%
| 1 | 4.5 % | 2 | 2.3 % | +51.98% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 23/17/23 | |
Stijn Vlaminck
CTO | Chief Tech/Sci/R&D Officer | - | 01/21/01 |
Graham Dixon
CTO | Chief Tech/Sci/R&D Officer | 63 | 01/19/01 |
Fanny Rozenberg
SEC | Corporate Secretary | - | - |
Laurence Schyns
HRO | Human Resources Officer | - | 01/21/01 |
Cedric Darcis
LAW | General Counsel | - | - |
Benjamin Brands
PRN | Corporate Officer/Principal | - | 01/09/01 |
Corporate Officer/Principal | - | 01/13/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jacques Galloy
BRD | Director/Board Member | 53 | 29/23/29 |
Christian Homsy
CHM | Chairman | 65 | 29/23/29 |
Valérie Gordenne
BRD | Director/Board Member | 51 | 20/21/20 |
Founder | 75 | 08/99/08 | |
Inge Beernaert
BRD | Director/Board Member | - | 29/23/29 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 69,108,397 | 56,443,924 ( 81.67 %) | 0 | 81.67 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
4,221,815 | 4.96% | 19,941,237 $ |
Company contact information
Group companies
Name | Category and Sector |
---|---|
Estetra SRL
Estetra SRL Pharmaceuticals: MajorHealth Technology Part of Mithra Pharmaceuticals SA, Estetra SRL is a Belgian pharmaceutical company that develops drugs. The private company is based in Grâce-Hollogne, Belgium. |
Pharmaceuticals: Major
|
Sector
Sales per region
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-82.78% | 15.94M | |
-4.06% | 86.13B | |
+1.32% | 39.82B | |
+56.59% | 25.23B | |
-14.73% | 15.36B | |
-8.82% | 11.95B | |
-16.16% | 11.6B | |
-43.00% | 11.51B | |
+6.14% | 8.71B | |
-7.02% | 8.12B |
- Stock Market
- Equities
- MITRA Stock
- Company Mithra Pharmaceuticals S.A.